In COVID-19, there is a striking loss of T cells, particularly of naïve CD4+ T cells [10, 11], but many effector and memory subsets are proportionally increased (although due to lymphopenia this may still represent a reduction in absolute numbers). The gene discussed is CD4; the disease is COVID-19.